Balachandran VP, Beatty GL, Dougan SK. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities. Gastroenterology. 2019;156:2056–72.

Article  CAS  PubMed  Google Scholar 

Wang D, Liu C, Zhou Y, et al. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis. Radiat Oncol. 2020;15:107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riquelme E, Zhang Y, Zhang L, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019;178:795-806.e12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chandana S, Babiker HM, Mahadevan D. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC). Expert Opin Investig Drugs. 2019;28:161–77.

Article  CAS  PubMed  Google Scholar 

Singhi AD, Koay EJ, Chari ST, et al. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology. 2019;156:2024–40.

Article  PubMed  Google Scholar 

Tomaino B, Cappello P, Capello M, et al. Autoantibody signature in human ductal pancreatic adenocarcinoma. J Proteome Res. 2007;6:4025–31.

Article  CAS  PubMed  Google Scholar 

Cappello P, Tomaino B, Chiarle R, et al. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer. 2009;125:639–48.

Article  CAS  PubMed  Google Scholar 

Capello M, Ferri-Borgogno S, Cappello P, et al. α-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J. 2011;278:1064–74.

Article  CAS  PubMed  Google Scholar 

Principe M, Borgoni S, Cascione M, et al. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J Hematol Oncol. 2017;10:16.

Article  PubMed  PubMed Central  Google Scholar 

Principe M, Ceruti P, Shih NY, et al. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells. Oncotarget. 2015;6:11098–113.

Article  PubMed  PubMed Central  Google Scholar 

Cappello P, Rolla S, Chiarle R, et al. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology. 2013;144:1098–106.

Article  CAS  PubMed  Google Scholar 

Cappello P, Curcio C, Mandili G, et al. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. Cancers (Basel). 2018;10:51.

Article  PubMed  Google Scholar 

Hirsch E, Novelli F. Cancer: natural-born killers unleashed. Nature. 2014;510:342–3.

Article  CAS  PubMed  Google Scholar 

Kaneda MM, Cappello P, Nguyen AV, et al. Macrophage PI3Kγ drives pancreatic ductal adenocarcinoma progression. Cancer Discov. 2016;6:870–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gabriel ANA, Jiao Q, Yvette U, et al. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance. Pancreatology. 2020;20:79–88.

Article  Google Scholar 

Loi M, Di Paolo D, Becherini P, et al. The use of the orthotopic model to validate antivascular therapies for cancer. Int J Dev Biol. 2011;55:547–55.

Article  CAS  PubMed  Google Scholar 

Li G, Zhao L. Sorafenib-loaded hydroxyethyl starch-TG100-115 micelles for the treatment of liver cancer based on synergistic treatment. Drug Deliv. 2019;26:756–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Consolino L, Longo DL, Dastrù W, et al. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging. Int J Cancer. 2016;139:404–13.

Article  CAS  PubMed  Google Scholar 

Zampini MA, Buizza G, Paganelli C, et al. Perfusion and diffusion in meningioma tumors: a preliminary multiparametric analysis with dynamic susceptibility contrast and intravoxel incoherent motion MRI. Magn Reson Imaging. 2020;67:69–78.

Article  PubMed  Google Scholar 

Donofrio G, Tebaldi G, Lanzardo S, et al. Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells. Oncoimmunology. 2018;7: e1494108.

Article  PubMed  PubMed Central  Google Scholar 

Giovarelli M, Cappello P, Forni G, et al. Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. J Immunol. 2000;164:3200–6.

Article  CAS  PubMed  Google Scholar 

Lambert SL, Okada CY, Levy R. TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection. J Immunol. 2004;172:929–36.

Article  CAS  PubMed  Google Scholar 

Corbière V, Chapiro J, Stroobant V, et al. Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases. Cancer Res. 2011;71:1253–62.

Article  PubMed  Google Scholar 

Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41:529–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falcomatà C, Bärthel S, Widholz SA, et al. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nat Cancer. 2022;3:318–36.

Article  PubMed  PubMed Central  Google Scholar 

Johnson BA, Yarchoan M, Lee V, et al. Strategies for increasing pancreatic tumor immunogenicity. Clin Cancer Res. 2017;23:1656–69.

Article  PubMed  PubMed Central  Google Scholar 

Popovic A, Jaffee EM, Zaidi N. Emerging strategies for combination checkpoint modulators in cancer immunotherapy. J Clin Invest. 2018;128:3209–18.

Article  PubMed  PubMed Central  Google Scholar 

Mandili G, Curcio C, Bulfamante S, et al. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. J Immunother Cancer. 2020;8: e001071.

Article  PubMed  PubMed Central  Google Scholar 

Ali K, Soond DR, Pineiro R, et al. Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer. Nature. 2014;510:407–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, et al. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer. Oncotarget. 2014;5:4651–64.

Article  PubMed  PubMed Central  Google Scholar 

Shalapour S, Font-Burgada J, Di Caro G, et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 2015;521:94–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bruno T. New predictors for immunotherapy responses sharpen our view of the tumour microenvironment. Nature. 2020;577:474–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sautes̀-Fridman C, Petitprez F, Calderaro J, et al. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307–25.

Article  PubMed  Google Scholar 

Joshi NS, Akama-Garren EH, Lu Y, et al. Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-Tumor T Cell Responses. Immunity. 2015;43:579–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu G, Nemoto S, Mailloux AW, et al. Induction of tertiary lymphoid structures with antitumor function by a lymph node-derived stromal cell line. Front Immunol. 2018;9:1609.

Article  PubMed  PubMed Central  Google Scholar 

Castino GF, Cortese N, Capretti G, et al. Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. Oncoimmunology. 2015;5: e1085147.

Article  PubMed  PubMed Central  Google Scholar 

Li K, Tandurella JA, Gai J, et al. Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy. Cancer Cell. 2022;40:1374–91.

Article  CAS